MEK1 Derived Peptide Inhibitor 1 is a biomedical product used for treating cancer by specifically targeting the MEK1 enzyme. This inhibitor peptide effectively blocks the activation of MEK1, a critical protein involved in cancer cell growth and proliferation. Its high specificity ensures minimal off-target effects, making it a promising candidate for cancer therapy.
CAT# | GR2210 |
CAS | 355367-87-2 |
M.F/Formula | C68H118N18O17S |
M.W/Mr. | 1491.84 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Peptide YY is referred to as PYY. Its structure is highly homologous with pancreatic polypeptide (PP) and neurop ...
Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...
Gonadorelin acetate, a synthetic decapeptide with sequence Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, is a gon ...
Peptides are the ideal drug molecules because of their high affinity, high selectivity, low toxicity, and easy synthesis. Sci ...
PAC-113, as well as a new type of Trp-rich peptide, is a 12 amino-acid fragment of the saliva protein histatin 5 ...